Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?

A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes

(2016) Sandro Gentile et al.   SpringerPlus

Frequency of Lipohypertrophy and Associated Risk Factors in Young Patients with Type 1 Diabetes: A Cross-Sectional Study

(2016) Ayman A. Al Hayek et al.   Diabetes Therapy

Frequency of Lipohypertrophy and Associated Risk Factors in Young Patients with Type 1 Diabetes: A Cross-Sectional Study

(2016) Ayman A. Al Hayek et al.   Diabetes Therapy

Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes

(2013) M. Blanco et al.   DIABETES & METABOLISM

Cromolyn Sodium for Insulin-Induced Lipoatrophy: Old Drug, New Use

(2013) E.-J. Phua et al.   DIABETES CARE

Efficacy, Safety, and Tolerability of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus: An Integrated Analysis of the DURATION Trials

(2013) Michael Grimm et al.   POSTGRADUATE MEDICINE

Encapsulation of Exenatide in Poly-(d,l-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes

(2011) Mary Beth DeYoung et al.   Diabetes Technology & Therapeutics

Metabolic consequences of incorrect insulin administration techniques in aging subjects with diabetes

(2010) Sandro Gentile et al.   ACTA DIABETOLOGICA

Pathogenesis and treatment of HIV lipohypertrophy

(2010) Vivien L Leung et al.   CURRENT OPINION IN INFECTIOUS DISEASES

New injection recommendations for patients with diabetes

(2010) A. Frid et al.   DIABETES & METABOLISM

DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks

(2010) J. B. Buse et al.   DIABETES CARE

Correlates of Insulin Injection Omission

(2010) M. Peyrot et al.   DIABETES CARE

Results and analysis of the 2008-2009 Insulin Injection Technique Questionnaire survey

(2010) Carina DE CONINCK et al.   Journal of Diabetes

Barriers to Insulin Injection Therapy

(2009) Richard R. Rubin et al.   DIABETES EDUCATOR

Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors

(2009) H. Hauner et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature

(2009) Andreas Holstein et al.   Expert Opinion On Drug Safety

Cutaneous side effects of anti–tumor necrosis factor biologic therapy: A clinical review

(2009) Aikaterini-Evaggelia Moustou et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Lipodystrophy in Patients with Acromegaly Receiving Pegvisomant

(2008) Vivien S. Bonert et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Foreign body reaction to biomaterials

(2008) James M. Anderson et al.   SEMINARS IN IMMUNOLOGY